XW0H7X8Introduction of Broad Consortium Microbiota-based Live Biotherapeutic Suspension into Lower GI, Via Natural or Artificial Opening, New Technology Group 8

New Technology›Anatomical Regions›Introduction
  • Billable / Specific Code
ICD-10-PCS XW0H7X8
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

XW0H7X8 is a billable ICD-10-PCS procedure code for Introduction of Broad Consortium Microbiota-based Live Biotherapeutic Suspension into Lower GI, Via Natural or Artificial Opening, New Technology Group 8. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products. The Alphabetic Index lists this code under Broad Consortium Microbiota-based Live Biotherapeutic Suspension. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Administration of therapeutic substances, NEC.

Code Identity

ICD-10-PCS Code
XW0H7X8
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Broad Consortium Microbiota-based Live Biotherapeutic Suspension into Lower GI, Via Natural or Artificial Opening, New Technology Group 8
Short Description
Introduce Micrbi Liv Biot in Low GI, Via Opening, New Tech 8
Parent Code
XW0

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation0Introduction
4BodyPartHLower GI
5Approach7Via Natural or Artificial Opening
6Device/Substance/TechnologyXBroad Consortium Microbiota-based Live Biotherapeutic Suspension
7Qualifier8New Technology Group 8

In the ICD-10-PCS Alphabetic Index

The FY 2027 ICD-10-PCS Alphabetic Index refers to XW0H7X8 as Broad Consortium Microbiota-based Live Biotherapeutic Suspension. These index entries lead to this code:

Broad Consortium Microbiota-based Live Biotherapeutic Suspension
Direct entry for this code
New Technology, Broad Consortium Microbiota-based Live Biotherapeutic Suspension
Direct entry for this code
REBYOTA(R)
Anatomy or device term that leads here
Iloprost
Leads to this code's table
Sarilumab
Leads to this code's table
Posoleucel
Leads to this code's table
Rezafungin
Leads to this code's table
Treosulfan
Leads to this code's table
Baricitinib
Leads to this code's table
Sabizabulin
Leads to this code's table
Tocilizumab
Leads to this code's table
Caplacizumab
Leads to this code's table
COVID-19 Vaccine
Leads to this code's table
Inebilizumab-cdon
Leads to this code's table
Sulbactam-Durlobactam
Leads to this code's table

To code broad consortium microbiota-based live biotherapeutic suspension, open the FY 2027 ICD-10-PCS Alphabetic Index at Broad Consortium Microbiota-based Live Biotherapeutic Suspension. The entry lists XW0H7X8 directly as a complete, billable code.

Browse the full ICD-10-PCS Alphabetic Index →

Clinical Classification (CCSR)

AHRQ groups this procedure code into these clinical categories.

ADM021
Administration of therapeutic substances, NEC
Clinical domain: Administration of Therapeutic Substances

Code History

Replaces previously assigned code(s):
  • 3E0H7GC — Introduction of Oth Therap Subst into Low GI, Via Opening

Similar Procedure Codes

Questions About XW0H7X8

Is XW0H7X8 a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Broad Consortium Microbiota-based Live Biotherapeutic Suspension into Lower GI, Via Natural or Artificial Opening, New Technology Group 8 on inpatient claims from October 1, 2026 through September 30, 2027.

What is the ICD-10-PCS code for broad Consortium Microbiota-based Live Biotherapeutic Suspension?

The ICD-10-PCS Alphabetic Index lists Broad Consortium Microbiota-based Live Biotherapeutic Suspension under code XW0H7X8, Introduction of Broad Consortium Microbiota-based Live Biotherapeutic Suspension into Lower GI, Via Natural or Artificial Opening, New Technology Group 8, billable on inpatient claims in fiscal year 2027.

What do the characters in XW0H7X8 mean?

The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character H is the BodyPart (Lower GI); the 5th character 7 is the Approach (Via Natural or Artificial Opening); the 6th character X is the Device/Substance/Technology (Broad Consortium Microbiota-based Live Biotherapeutic Suspension); the 7th character 8 is the Qualifier (New Technology Group 8).